AAAAAA

   
Results: 1-15 |
Results: 15
INFLUENCE OF CHOLESTYRAMINE ON THE PHARMACOKINETICS OF CERIVASTATIN
Authors: MUCK W RITTER W FREY R WETZELSBERGER N LUCKER PW KUHLMANN J
Citation: W. Muck et al., INFLUENCE OF CHOLESTYRAMINE ON THE PHARMACOKINETICS OF CERIVASTATIN, International journal of clinical pharmacology and therapeutics, 35(6), 1997, pp. 250-254
EFFECT OF BUFFERING ON PHARMACOKINETICS OF KETOPROFEN ENANTIOMERS IN MAN
Authors: FUDER H STIEGLER S WETZELSBERGER N WIECKHORST G LANGE R LUCKER PW
Citation: H. Fuder et al., EFFECT OF BUFFERING ON PHARMACOKINETICS OF KETOPROFEN ENANTIOMERS IN MAN, British journal of clinical pharmacology, 44(6), 1997, pp. 527-530
CONCOMITANT ADMINISTRATION OF THE ALPHA-GLUCOSIDASE INHIBITOR VOGLIBOSE (AO-128) DOES NOT ALTER THE PHARMACOKINETICS OF GLIBENCLAMIDE
Authors: KLEIST P EHRLICH A SUZUKI Y TIMMER W WETZELSBERGER N LUCKER PW FUDER H
Citation: P. Kleist et al., CONCOMITANT ADMINISTRATION OF THE ALPHA-GLUCOSIDASE INHIBITOR VOGLIBOSE (AO-128) DOES NOT ALTER THE PHARMACOKINETICS OF GLIBENCLAMIDE, European Journal of Clinical Pharmacology, 53(2), 1997, pp. 149-152
THE ALPHA-GLUCOSIDASE INHIBITOR VOGLIBOSE (AO-128) DOES NOT CHANGE PHARMACODYNAMICS OR PHARMACOKINETICS OF WARFARIN
Authors: FUDER H KLEIST P BIRKEL M EHRLICH A EMEKLIBAS S MASLAK W STRIDDE E WETZELSBERGER N WIECKHORST G LUCKER PW
Citation: H. Fuder et al., THE ALPHA-GLUCOSIDASE INHIBITOR VOGLIBOSE (AO-128) DOES NOT CHANGE PHARMACODYNAMICS OR PHARMACOKINETICS OF WARFARIN, European Journal of Clinical Pharmacology, 53(2), 1997, pp. 153-157
INFLUENCE OF CHOLESTYRAMINE ON THE PHARMACOKINETICS OF CERIVASTATIN
Authors: RITTER W FREYL R WETZELSBERGER N LUCKER PW
Citation: W. Ritter et al., INFLUENCE OF CHOLESTYRAMINE ON THE PHARMACOKINETICS OF CERIVASTATIN, Atherosclerosis, 130, 1997, pp. 123-123
VOGLIBOSE DOES NOT MODIFY PHARMACODYNAMICS OR PHARMACOKINETICS OF WARFARIN IN HEALTHY MAN
Authors: FUDER H KLEIST P STRIDDE E EHRLICH A EMEKLIBAS S MASLAK W WIECKHORST G BIRKEL M WETZELSBERGER N
Citation: H. Fuder et al., VOGLIBOSE DOES NOT MODIFY PHARMACODYNAMICS OR PHARMACOKINETICS OF WARFARIN IN HEALTHY MAN, Diabetologia, 40, 1997, pp. 1210-1210
EFFECT OF BUFFERING ON PHARMACOKINETICS OF KETOPROFEN (KN) ENANTIOMERS IN MAN
Authors: LANGE R FUDER H BIRKEL M WETZELSBERGER N LUCKER PW
Citation: R. Lange et al., EFFECT OF BUFFERING ON PHARMACOKINETICS OF KETOPROFEN (KN) ENANTIOMERS IN MAN, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 26-26
NO PHARMACOKINETIC INTERACTION BETWEEN THE ALPHA-GLUCOSIDASE INHIBITOR VOGLIBOSE (AO-128) AND GLIBENCLAMIDE IN HEALTHY-SUBJECTS
Authors: FUDER H KLEIST P EHRLICH A TIMMER W SUZUKI Y BIRKEL M WETZELSBERGER N LUCKER PW
Citation: H. Fuder et al., NO PHARMACOKINETIC INTERACTION BETWEEN THE ALPHA-GLUCOSIDASE INHIBITOR VOGLIBOSE (AO-128) AND GLIBENCLAMIDE IN HEALTHY-SUBJECTS, Naunyn-Schmiedeberg's archives of pharmacology, 354(4), 1996, pp. 123-123
RELATIVE BIOAVAILABILITY OF DL-OXYFEDRINE-ASTERISK-HCL AFTER SINGLE-DOSE ORAL-ADMINISTRATION OF TABLETS AS COMPARED TO EQUIMOLAR SOLUTIONS
Authors: WETZELSBERGER N BIRKEL M FUDER H LUCKER PW STIEGLER S SCHEITHAUER S THUMMLER D
Citation: N. Wetzelsberger et al., RELATIVE BIOAVAILABILITY OF DL-OXYFEDRINE-ASTERISK-HCL AFTER SINGLE-DOSE ORAL-ADMINISTRATION OF TABLETS AS COMPARED TO EQUIMOLAR SOLUTIONS, Methods and findings in experimental and clinical pharmacology, 17(3), 1995, pp. 185-191
PHARMACOKINETICS AND RELATIVE BIOAVAILABILITY AFTER SINGLE-DOSE ADMINISTRATION OF 25 MG KETOPROFEN SOLUTION AS COMPARED TO TABLETS
Authors: STIEGLER S BIRKEL M JOST V LANGE R LUCKER PW WETZELSBERGER N
Citation: S. Stiegler et al., PHARMACOKINETICS AND RELATIVE BIOAVAILABILITY AFTER SINGLE-DOSE ADMINISTRATION OF 25 MG KETOPROFEN SOLUTION AS COMPARED TO TABLETS, Methods and findings in experimental and clinical pharmacology, 17(2), 1995, pp. 129-134
STUDY ON THE ABSOLUTE BIOAVAILABILITY OF QUININE AND THEOPHYLLINE FROM TABLETS AFTER SINGLE-DOSE ORAL-ADMINISTRATION AS COMPARED TO INTRAVENOUS-INFUSION IN HEALTHY MALE NONSMOKING VOLUNTEERS
Authors: FUDER H HERZOG R VAUPEL W WETZELSBERGER N LUCKER PW
Citation: H. Fuder et al., STUDY ON THE ABSOLUTE BIOAVAILABILITY OF QUININE AND THEOPHYLLINE FROM TABLETS AFTER SINGLE-DOSE ORAL-ADMINISTRATION AS COMPARED TO INTRAVENOUS-INFUSION IN HEALTHY MALE NONSMOKING VOLUNTEERS, Methods and findings in experimental and clinical pharmacology, 16(9), 1994, pp. 651-660
BIOEQUIVALENCE OF 2 COMMERCIALLY AVAILABLE TAMOXIFEN TABLET FORMULATIONS IN HEALTHY MALE-VOLUNTEERS
Authors: LORKOWSKI G LUCKER PW PETERSEN G SCHNITZLER M WETZELSBERGER N
Citation: G. Lorkowski et al., BIOEQUIVALENCE OF 2 COMMERCIALLY AVAILABLE TAMOXIFEN TABLET FORMULATIONS IN HEALTHY MALE-VOLUNTEERS, Methods and findings in experimental and clinical pharmacology, 16(6), 1994, pp. 443-447
IMPROVED INTERNALLY STANDARDIZED GC-ECD METHOD FOR THE DETERMINATION OF FREE AND CONJUGATED TRICLOSAN (IRGASAN DP300) IN HUMAN PLASMA
Authors: BIRKEL M ERKING W WETZELSBERGER N
Citation: M. Birkel et al., IMPROVED INTERNALLY STANDARDIZED GC-ECD METHOD FOR THE DETERMINATION OF FREE AND CONJUGATED TRICLOSAN (IRGASAN DP300) IN HUMAN PLASMA, Methods and findings in experimental and clinical pharmacology, 15(9), 1993, pp. 623-627
INVESTIGATION INTO A POSSIBLE DRUG-DRUG INTERACTION BETWEEN WARFARIN AND NIMESULIDE IN HEALTHY-VOLUNTEERS
Authors: THEISS U TIMMER W WIECKHORST G MACCIOCCHI A WETZELSBERGER N
Citation: U. Theiss et al., INVESTIGATION INTO A POSSIBLE DRUG-DRUG INTERACTION BETWEEN WARFARIN AND NIMESULIDE IN HEALTHY-VOLUNTEERS, Methods and findings in experimental and clinical pharmacology, 15(9), 1993, pp. 629-635
LUCKER,PETER,WOLFGANG ON THE OCCASION OF HIS 60TH BIRTHDAY
Authors: WETZELSBERGER N
Citation: N. Wetzelsberger, LUCKER,PETER,WOLFGANG ON THE OCCASION OF HIS 60TH BIRTHDAY, Arzneimittel-Forschung, 43-2(11), 1993, pp. 1240-1240
Risultati: 1-15 |